Back to
RA Capital Management, L.P.
SLDBN
Showing 0 of 17 quarters
Position history for
RA Capital Management, L.P.'s holdings in SOLID BIOSCIENCES INC
As of its Q3 2022 13F, RA Capital Management held 12,367,873 shares of SLDBN (Solid Biosciences), worth $5.8M. RA Capital Management's 13F filings listed SLDBN from Q4 2018 to Q3 2022, 16 quarterly filings. SLDBN was 0.1% of RA Capital Management's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of SLDBN: T. Rowe Price Associates, Inc., Jennison Associates LLC, Citadel Advisors LLC